In Brief: Bayer/Andrx
This article was originally published in The Tan Sheet
Executive Summary
Bayer/Andrx: Enter agreement to develop a new OTC product using Ft. Lauderdale, Fla.-based Andrx' controlled-release drug delivery technologies and a Bayer affiliate's OTC expertise, Andrx announces Sept. 22. Details were not disclosed. Given the move to switch Rx products to OTCs, Andrx considers the arrangement with Bayer the "beginning of an ongoing relationship"...